C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader of Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center, shared a post on X:
“Highlights in Multiple Myeloma From ASCO and EHA 2024. Lots of New Exciting Data. Great For Patients!”
Read further.
Source: C. Ola Landgren/X